IBDEI1I1 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24248,2)
 ;;=^332840
 ;;^UTILITY(U,$J,358.3,24249,0)
 ;;=E87.0^^82^1049^2
 ;;^UTILITY(U,$J,358.3,24249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24249,1,3,0)
 ;;=3^Hyperosmolality & Hpernatremia
 ;;^UTILITY(U,$J,358.3,24249,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,24249,2)
 ;;=^5003018
 ;;^UTILITY(U,$J,358.3,24250,0)
 ;;=E87.1^^82^1049^3
 ;;^UTILITY(U,$J,358.3,24250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24250,1,3,0)
 ;;=3^Hypo-osmolality & Hyponatremia
 ;;^UTILITY(U,$J,358.3,24250,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,24250,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,24251,0)
 ;;=E10.10^^82^1050^15
 ;;^UTILITY(U,$J,358.3,24251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24251,1,3,0)
 ;;=3^DM Type 1 w/ Ketoacidosis w/o Coma
 ;;^UTILITY(U,$J,358.3,24251,1,4,0)
 ;;=4^E10.10
 ;;^UTILITY(U,$J,358.3,24251,2)
 ;;=^5002587
 ;;^UTILITY(U,$J,358.3,24252,0)
 ;;=E10.11^^82^1050^14
 ;;^UTILITY(U,$J,358.3,24252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24252,1,3,0)
 ;;=3^DM Type 1 w/ Ketoacidosis w/ Coma
 ;;^UTILITY(U,$J,358.3,24252,1,4,0)
 ;;=4^E10.11
 ;;^UTILITY(U,$J,358.3,24252,2)
 ;;=^5002588
 ;;^UTILITY(U,$J,358.3,24253,0)
 ;;=E10.21^^82^1050^5
 ;;^UTILITY(U,$J,358.3,24253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24253,1,3,0)
 ;;=3^DM Type 1 w/ Diab Nephropathy
 ;;^UTILITY(U,$J,358.3,24253,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,24253,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,24254,0)
 ;;=E10.22^^82^1050^3
 ;;^UTILITY(U,$J,358.3,24254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24254,1,3,0)
 ;;=3^DM Type 1 w/ Diab CKD
 ;;^UTILITY(U,$J,358.3,24254,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,24254,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,24255,0)
 ;;=E10.29^^82^1050^21
 ;;^UTILITY(U,$J,358.3,24255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24255,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,24255,1,4,0)
 ;;=4^E10.29
 ;;^UTILITY(U,$J,358.3,24255,2)
 ;;=^5002591
 ;;^UTILITY(U,$J,358.3,24256,0)
 ;;=E10.311^^82^1050^9
 ;;^UTILITY(U,$J,358.3,24256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24256,1,3,0)
 ;;=3^DM Type 1 w/ Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,24256,1,4,0)
 ;;=4^E10.311
 ;;^UTILITY(U,$J,358.3,24256,2)
 ;;=^5002592
 ;;^UTILITY(U,$J,358.3,24257,0)
 ;;=E10.319^^82^1050^10
 ;;^UTILITY(U,$J,358.3,24257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24257,1,3,0)
 ;;=3^DM Type 1 w/ Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,24257,1,4,0)
 ;;=4^E10.319
 ;;^UTILITY(U,$J,358.3,24257,2)
 ;;=^5002593
 ;;^UTILITY(U,$J,358.3,24258,0)
 ;;=E10.3211^^82^1050^16
 ;;^UTILITY(U,$J,358.3,24258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24258,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,24258,1,4,0)
 ;;=4^E10.3211
 ;;^UTILITY(U,$J,358.3,24258,2)
 ;;=^5138279
 ;;^UTILITY(U,$J,358.3,24259,0)
 ;;=E10.3212^^82^1050^17
 ;;^UTILITY(U,$J,358.3,24259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24259,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,24259,1,4,0)
 ;;=4^E10.3212
 ;;^UTILITY(U,$J,358.3,24259,2)
 ;;=^5138280
 ;;^UTILITY(U,$J,358.3,24260,0)
 ;;=E10.3213^^82^1050^18
 ;;^UTILITY(U,$J,358.3,24260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24260,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
 ;;^UTILITY(U,$J,358.3,24260,1,4,0)
 ;;=4^E10.3213
